Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, United States ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

Planegg/Martinsried, November 26, 2024.Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

A team of UC Davis Health researchers has shown that CD34+ stem cells can be safely administered into retinitis pigmentosa ...

Cells can now be genetically programmed to record their histories within their genomes, a development that could ...

Roche's acquisition of Poseida Therapeutics (PSTX) for $1.5B joins the growing trend of cell therapies in M&A activities. Check out my review of this deal.

Lehigh Valley Topper Cancer Institute, which is now part of the NCI Designated Sidney Kimmel Comprehensive Cancer Center at Jefferson Health, has announced it is now offering treatment using ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

Medigene has said it will cut 40% of its workforce and delay the start of clinical trials of its lead asset as it re-jigs its ...